RU94028669A - VECTOR CONSTRUCTION, RECOMBINANT VIRUSES, RECOMBINANT RETROVIRUS, TARGET CELLS, COMPOSITION, COMPOSITION APPLICATION - Google Patents

VECTOR CONSTRUCTION, RECOMBINANT VIRUSES, RECOMBINANT RETROVIRUS, TARGET CELLS, COMPOSITION, COMPOSITION APPLICATION

Info

Publication number
RU94028669A
RU94028669A RU94028669/13A RU94028669A RU94028669A RU 94028669 A RU94028669 A RU 94028669A RU 94028669/13 A RU94028669/13 A RU 94028669/13A RU 94028669 A RU94028669 A RU 94028669A RU 94028669 A RU94028669 A RU 94028669A
Authority
RU
Russia
Prior art keywords
composition
recombinant
altered
target cells
vector construction
Prior art date
Application number
RU94028669/13A
Other languages
Russian (ru)
Inventor
Чада Сунил
Боднер Мордечай
Дж.Джолли Дуглас
Р. Барбер Джек
Е. ДеДжесус Кейти
Original Assignee
Вайаджин Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вайаджин Инк. filed Critical Вайаджин Инк.
Publication of RU94028669A publication Critical patent/RU94028669A/en

Links

Claims (1)

Изобретение представляет метод для разрушения определенных опухолевых клеток, включающий введение теплокровному животному векторной конструкции, направляющей экспрессию по крайней мере одной иммуногенной, не канцерогенной формы измененного клеточного компонента, в норме ассоциированного с данными опухолевыми клетками. Представлены также векторные конструкции, направляющие экспрессию измененных клеточных компонентов. Характерные примеры измененных клеточных компонентов включают ros*, p 53, *Rb, измененный протеин, кодируемый геном опухоли Вилмса, убиквитин , ДСС, АPC, МСС, nen, измененный рецептор и bes/abl. Также представлены рекомбинантные вирусы, несущие векторную конструкцию, клетки-мишени, инфицированные рекомбинантным вирусом, и фармацевтические композиции, содержащие рекомбинантный вирус и фармацевтически приемлемый носитель или растворитель.The invention provides a method for destroying certain tumor cells, comprising administering to a warm-blooded animal a vector construct directing the expression of at least one immunogenic, non-carcinogenic form of an altered cellular component normally associated with these tumor cells. Also presented are vector constructs that direct the expression of altered cellular components. Representative examples of altered cellular components include ros * , p 53, * Rb, altered protein encoded by the Wilms tumor gene, ubiquitin, DSS, APC, MCC, nen, altered receptor, and bes / abl. Also presented are recombinant viruses carrying the vector construct, target cells infected with the recombinant virus, and pharmaceutical compositions containing the recombinant virus and a pharmaceutically acceptable carrier or diluent.
RU94028669/13A 1991-11-29 1992-11-30 VECTOR CONSTRUCTION, RECOMBINANT VIRUSES, RECOMBINANT RETROVIRUS, TARGET CELLS, COMPOSITION, COMPOSITION APPLICATION RU94028669A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/800328 1991-11-29

Publications (1)

Publication Number Publication Date
RU94028669A true RU94028669A (en) 1996-03-27

Family

ID=

Similar Documents

Publication Publication Date Title
FI942503A (en) Immunotherapeutic anticancer vector constructs
WO1991002805A3 (en) Recombinant retroviruses delivering vector constructs to target cells
GB2236753B (en) Recombinant retroviruses directing the expression of therapeutic agents in target cells
DK11789A (en) RECOMBINANT VACCINIA VIRA
DE68903846T2 (en) NEW GALENIC FORM OF FENOFIBRATE.
ATE554750T1 (en) PREPARATIONS CONTAINING HYDROPHOBIC PHARMACEUTICAL ACTIVE INGREDIENTS
DE59410380D1 (en) ENDOSOMOLYTICALLY EFFECTIVE PARTICLES
DE68927025D1 (en) HIV-2 virus variants
NO933261D0 (en) MIXING FOR IMPROVEMENT OF THE IMMUNE DEFENSE
BR0306925A (en) Stabilized adenovirus formulations
KR860005636A (en) Injection composition containing Spergualin as an active ingredient and its preparation method.
AR003135A1 (en) RECOMBINANT BACULOVIRUSES, A VACCINE THAT CONTAINS THEM, AND THE USE OF THE SAME TO PREPARE A VACCINE USEFUL TO AVOID OR DECREASE THE DISEASE CAUSED BY FELINE IMMUNODEFICIENCY VIRUSES.
DK1149910T3 (en) Pharmaceutical preparation for treating papillomavirus tumors and infection
DK0512011T3 (en) Blood factors produced by recombinant DNA technology, method of expression of the blood factors, and vaccinia virus recombinants used in the method
EA200000240A1 (en) CONNECTIONS PREVENTING THE EFFECT OF EARLY TURNING OF MEDICINES
RU94028669A (en) VECTOR CONSTRUCTION, RECOMBINANT VIRUSES, RECOMBINANT RETROVIRUS, TARGET CELLS, COMPOSITION, COMPOSITION APPLICATION
DK0781344T3 (en) Newly known implant and novel vector for the treatment of acquired diseases
RU2006118106A (en) CHIMERIC Adenovirus VECTOR TYPE 5 / TYPE 35
IT8522989A0 (en) FRACTION OBTAINED FROM LISTERIA MONOCYTOGENES HAVING THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
YU11991A (en) RECOMBINANTLY PRODUCED BLOOD FACTOR AND PROCEDURE FOR EXPRESSION OF THESE BLOOD FACTORS AS WELL AS VACCINIAL VIRUS VIRUCINES USED IN THIS PROCEDURE
ITMI922332A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF PARATORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS OR RECTAL RELATED PEPTIDES.
TH31605A (en) Recombinant raccoon fox virus and its use against feline autoimmune viral infection
ES2119987T3 (en) MONOACETIC DERIVATIVES OF PEPTIDES LEU-PHE-ALA AND ALA-LEU-PHE AND THEIR USE IN THE IDENTIFICATION AND DESTRUCTION OF TUMOR CELLS AND CELLS INFECTED BY VIRUSES.